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Tetrahydroaminoacridine (THA) is a centrally active anticholinesterase that also interacts with neuronal K + and Na + channels and cardiac Ca 2 + 
channels. The effects of  T HA on neuronal voltage-dependent Ca 2 + channels are not known. We tested the effects of  THA (25 nM 250 ItM) on 
the Ca z + current components  of  acutely dissociated rat nodose ganglion and dorsal root ganglion (DRG) neurons using the whole cell patch clamp 
recording technique. T H A  reduced the low-threshold (T) and high-threshold (N/L) Ca z ~ current components  in a concentration-dependent manner  
(ICs0~ 125 ltM for T: ~_ 80/~M for N/L). Minimal current reduction was seen below ~ 10/*M. Our results show that THA reduces voltage-dependent 
Ca 2+ currents in rodent sensory neurons suggesting another means by which THA may affect Cae+-dependent physiologic processes. 
Tetrahydroaminoacridine (THA) is a centrally active 
anticholinesterase that has been tested in the palliative 
treatment of  patients with Alzheimer's disease [6, 21]. In 
addition to its anticholinesterase activity, T H A  is known 
to have effects on several types of  neuronal voltage-de- 
pendent ion channels. T H A  is structurally related to 4- 
aminopyridine, a K + channel blocker, and has been 
shown to block K + currents in several studies [1, 3, 4, 
7, 10, 12, 13, 15, 16, 18, 20]. T H A  can also block inward 
Na + currents [16] and inhibit Na + inactivation [18]. In 
studies of  guinea pig ventricular myocytes [15] and rab- 
bit sinoatrial node [13], T H A  reduced slow inward vol- 
tage-dependent Ca 2+ currents. The effects of  T H A  on 
neuronal voltage-dependent Ca 2+ currents are not 
known. 
We examined the effect of  T H A  on the Ca 2+ current 
components of  acutely dissociated rat nodose and dorsal 
root ganglion (DRG)  neurons using the whole cell patch 
clamp technique. These neurons have Ca 2+ current com- 
ponents [2, 9, 19] similar to those initially described in 
chick D R G  neurons [5] and subsequently in mouse 
D R G  neurons [8]. These Ca 2+ current components  in- 
clude a transient low-threshold current (T), a transient 
high-threshold current (N), and a slowly inactivating 
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high-threshold current (L). Our results show that T H A  
reduced T and N/L Ca 2+ currents in rat nodose and 
D R G  neurons. 
Nodose ganglia were taken from 5 10-day-old rats, 
placed in oxygenated Ca 2+- and Mg2÷-free buffer, 
treated with collagenase (1 mg/ml), and incubated at 
3 7 C  in a 93% air/'7% CO2 atmosphere for 30 min. Fol- 
lowing addition of enzyme inhibitor (5% fetal calf se- 
rum), the neurons were triturated, centrifuged, resus- 
pended, plated, and reincubated prior to use. DRGs  
were taken from 15 25-day-old animals ( ~ 2 0  ganglia/ 
animal), placed in Minimal Essential Medium (MEM), 
minced with micro-dissecting scissors, treated with colla- 
genase (3 mg/ml), and incubated for 50 min before addi- 
tion of trypsin (1 mg/ml), with continued incubation for 
10 rain. The ganglia were removed, placed in MEM, cen- 
trifuged, triturated, recentrifuged, resuspended, plated, 
and reincubated prior to use. 
Recordings of Ca 2+ currents were made with glass 
micropipettes (1.5 2.5 M ~ )  filled with a solution of (in 
mM): CsC1 140, CsOH 30, HEPES 10, EGTA 10, ATP 
5 and GTP 0.1 (pH 7.2 7.3, ~300 mOsm). Neurons 
were bathed in a solution of (in mM): choline CI 67, 
TEA 100, glucose 5.6, KCI 5.3, CaCI2 5.0, MgCI2 0.8, 
HEPES 10 (pH 7.35, - 3 2 0  mOsm). Cesium and TEA 
were used to block K ÷ currents; choline was used to 
block Na + currents. Following sealing of the micropi- 
pette to the neuron and rupture of  the membrane patch, 
the neuron was hyperpolarized to a holding potential 
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( V h ) = - 9 0  mV to remove steady-state inactivation of 
Ca 2+ currents. The program pCLAMP (Axon Instru- 
ments) was used to generate voltage step commands and 
to digitize (5.6 kHz) and store current traces. All experi- 
ments were conducted at room temperature. 
T currents were isolated by evoking currents from a 
Vh = - 9 0  mV at clamp potentials (Vc) at or positive to 
- 5 5  inV. Typically, T currents were evoked by using 
voltage steps of  100 ms duration delivered every 5 s in 
5 mV increments ranging from a Vc -- - 65 to - 20 mV. T 
currents were measured at the point of peak inward cur- 
rent and at 100 ms. Maximal T current was the largest 
evoked peak T current evoked at a V~ (usually - 35 mV) 
negative to that at which more slowly inactivating cur- 
rent components (N/L) were evoked. This resulted in 
slight underestimation of  T current magnitude but al- 
lowed for examination of  those currents with little high- 
threshold current contamination. T currents were stable 
and showed little change in amplitude over the course of 
an experiment. T current magnitude varied among neu- 
rons from barely detectable to greater than 1.5 hA. 
N/L currents were evoked from a Vh = - 90 mV (occa- 
sionally - 80 mV) at a Vc at or positive to - 20 mV and 
were measured at the point of peak inward current and 
at 100 ms. Maximal N/L current was the largest evoked 
high threshold current measured at peak current. Cur- 
rents were evoked at 1 min intervals and declined 30- 
50% during a 20 rain recording. Current rundown was 
estimated for each neuron from serial maximal N/L cur- 
rents evoked at 1 min intervals approximately 5 min al- 
ter patch rupture and prior to application of THA. 
T and N/L currents were leak subtracted for analysis 
using the inverse of currents evoked from hyperpolariz- 
ing voltage commands equal to the depolarizing com- 
mands used in evoking inward currents. Current activa- 
tion, current inactivation, and voltage-dependency were 
assessed for control and THA. Current activation was 
estimated using the time to the point of peak inward cur- 
rent. Current inactivation was estimated using the ratio 
of current at 100 ms/peak current. Voltage dependency 
was assessed by inspection of the current-voltage rela- 
tion. 
THA was prepared on the day of experiments by dis- 
solving it in external solution. The THA solution was 
drawn up into a blunt tipped (10--15/~m) micropipette 
which was kept out of the bath solution when not in use. 
THA was tested by positioning the micropipette tip ~ 50 
#m from the cell soma and applied by passive diffusion 
shortly before and during voltage step commands. The 
effects of THA applied by pressure ejection (l psi) were 
the same as those by passive diffusion. Control micropi- 
pettes contained external solution and were substituted 
sequentially with micropipettes containing different con- 
centrations of THA. 
THA was tested in 25 neurons: 20 nodose and 5 DRG. 
There was no observed difference in the effects of THA 
on the evoked Ca 2 + currents for the two neuronal types, 
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Fig. 1. Concentration-response curves for maximal T and N/L Ca 2+ currents tested in 25 nodose and dorsal root ganglion (DRG) neurons with 
THA (25 riM-250/~M). Each point represents the mean percent reduction of control maximal currents obtained by testing with THA in t-4 neurons 
(bars indicate S.E.M.). For each neuron studied, specific concentrations of THA were tested by single or multiple applications. Inset: leak-subtracted 
T and N/L currents in a nodose neuron for control (1) and THA (2) at l0 #M and 100 pM. 
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Fig. 2. Current-voltage relations for Ca 2+ currents measured in a D R G  neuron in the absence and presence of  T H A  (50/~M). Ca 2+ currents were 
evoked from a V , =  - 9 0  mV at a V~ ranging from - 100 to +40  mV. A: THA 's  effect on peak current amplitude. B: THA 's  effect on the current 
amplitude measured at ]00 ms (note change in ordinate scale). 
vous system have an increased sensitivity to THA.  Bene- 
ficial effects have been reported for nimodipine, a dihy- 
centration-response curve of  T H A  (25 nM-250/~M) on 
maximal T and N/L current reduction for all neurons 
studied. T H A  decreased peak current in a concentration- 
dependent manner  for both T (ICs0~ 125/tM) and N/L 
(ICs0~-80 ktM) currents. Minimal current reduction was 
seen below ~ 10/tM. At the highest concentration tested 
(250/~M), T current was reduced by 57%, and N/L cur- 
rent by 90%. Fig. 1 (inset) demonstrates the concentra- 
tion-dependent reduction of T and N/L  currents in a 
nodose neuron by T H A  (10/~M and 100/~M). T currents 
recovered fully within 1 min of T H A  application. N/L  
currents recovered fully within 1 min with T H A  (10/~M), 
but took 3 min to recover with T H A  (100 /~M) (not 
shown). Current activation was not changed with THA.  
Similarly, the amount  of  current inactivation was not 
changed with T H A  (10/~M), however, current inactiva- 
tion appeared to decrease with T H A  at higher concen- 
trations ( 100/~M), an effect seen in other neurons as well. 
This suggests that the apparent  decreased inactivation 
for T currents was due to either the late current consist- 
ing of a T current and a reduced N/L  current component  
or that there were two phases of  T current inactivation 
with the T H A  effect greater on the initial, larger compo-  
nent. For N/L currents, the initial current was reduced 
to a greater extent than late (100 ms) currents. This 
could be due to greater reduction of  the more rapidly 
inactivating N current than the slowly inactivating L 
current by T H A  or that T H A  causes a small increase in 
activation rate. Fig. 2 shows the current-voltage relation 
for Ca 2+ currents measured at peak current (A) and at 
100 ms (B) when tested with T H A  (50/~M). T H A  did not 
change the voltage-dependency of the evoked currents at 
peak or 100 ms. 
The main finding of  this study was that T H A  reversi- 
bly reduced whole cell voltage-dependent T and N/L 
Ca 2+ currents in a concentration-dependent manner in 
rat nodose and D R G  neurons. These results demon- 
strate that in addition to THA' s  known anticholinester- 
ase activity and its effects on K + and Na + currents in 
neuronal preparations, it can also cause marked reduc- 
tion of neuronal voltage-dependent Ca 2+ currents. Ca 2+ 
current reduction occurred without effect on current 
activation or inactivation, or on voltage dependency at 
T H A  concentrations ~<75 /~M. Several studies have 
shown THA's  ability to block different K + conduc- 
tances but T H A  has little to no effect on Ca2+-activated 
K + conductances [1, 3, 20]. Thus the block of Ca 2+ cur- 
rents seen in these experiments probably does not contri- 
bute to a secondary reduction of K + currents. THA's  
reduction of both T and N/L currents suggests that it 
may have diverse effects on Ca2+-dependent physiologic 
processes. N currents may be primary regulators of  the 
inhibition of  release of  neurotransmitters [11] and reduc- 
tion of these currents by T H A  may contribute to the 
observed inhibitory effect of  T H A  on depolarization- 
induced release of  7-aminobutyric acid (GABA) in rat 
cerebral cortex [3]. THA' s  reduction of cardiac slow 
inward Ca 2+ currents [13, 15] is likely mediated by L- 
type Ca 2+ channels and Ca 2+ current reduction in those 
studies may be qualitatively similar to the results found 
here. 
T H A  had little effect on Ca 2+ currents in the serum 
concentration range (20-300 nM) used in clinical trials 
in the treatment of  Alzheimer's disease [21]. Although 
rodent in vivo levels of  T H A  have been shown to be 10 
times higher in brain than plasma [14], a log unit shift 
of  the T H A  concentration-response curve in the present 
experiments would not have been significant since mini- 
mal current reduction was seen below ~ 10/~M. This re- 
sult suggests that if T H A  has any therapeutic effect in 
Alzheimer's disease, it is not likely due to reduction of 
Ca 2+ currents unless Ca 2+ channels in the central ner- 
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dropyridine derivative and Ca 2 + channel antagonist, in 
the management of primary degenerative dementia [22] 
and in animal models of aging and cognition [17]. 
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